Human-derived AD-tau seeded intracellular endogenous tau inclusions that contained AD-associated modifications (i.e. phosphorylation at the PHF1, AT8, and pS422 antibody epitopes) and adopted multiple pathogenic conformations (i.e. oligomers and exposure of an N-terminal phosphatase activating domain; PAD). Here, MAPT is linked to Alzheimer disease.